Sarepta Therapeutics Inc (SRPT) — Cash Flow Reinvestment Rate
Sarepta Therapeutics Inc (SRPT) has a Cash Flow Reinvestment Rate of 1.16x as of December 2025, reinvesting $151.71 Million (capex $5.83 Million plus investments $-145.88 Million) from operating cash flow of $131.21 Million. See Sarepta Therapeutics Inc (SRPT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sarepta Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sarepta Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sarepta Therapeutics Inc.
Annual Cash Flow Reinvestment Rate for Sarepta Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sarepta Therapeutics Inc. See Sarepta Therapeutics Inc (SRPT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.11x | $226.29 Million | $107.47 Million | $82.20 Million | — |